首页> 美国卫生研究院文献>BMC Cancer >Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel cisplatin and S-1: a retrospective observational study

【2h】

Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel cisplatin and S-1: a retrospective observational study

机译：回顾性观察研究：外渗性血小板凝集作为晚期胃癌患者术前多西他赛顺铂和S-1治疗后总体生存的替代指标的潜力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe theory of extravasated platelet aggregation in cancer lesions was recently introduced. We investigated the association of platelet aggregation in gastric cancer stroma with clinicopathological features, chemotherapeutic response, pathological response, and survival.

机译：背景技术最近介绍了在癌症病灶中外渗血小板聚集的理论。我们调查了胃癌基质中血小板聚集与临床病理特征，化学治疗反应，病理反应和生存的关系。

著录项

期刊名称 BMC Cancer
作者
Hiroto Saito; Sachio Fushida; Tomoharu Miyashita; Katsunobu Oyama; Takahisa Yamaguchi; Tomoya Tsukada; Jun Kinoshita; Hidehiro Tajima; Itasu Ninomiya; Tetsuo Ohta;
展开▼
作者单位

展开▼
年(卷),期 2017(17),-1
年度 2017
页码 294
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Gastric cancer Platelets Preoperative chemotherapy Chemoresistance Surrogate marker;

机译：胃癌;血小板;术前化疗;化学耐药性;替代指标;

相似文献

外文文献
中文文献
专利

1. Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study [J] . Hiroto Saito, Sachio Fushida, Tomoharu Miyashita, BMC Cancer . 2017,第1期

机译：回顾性观察性研究发现，血小板外聚集可能是晚期多西他赛，顺铂和S-1治疗的晚期胃癌患者总体生存的替代指标。
2. Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study [J] . Hiroto Saito, Sachio Fushida, Tomoharu Miyashita, BMC Cancer . 2017,第1期

机译：回顾性观察性研究发现，血小板外聚集可能是晚期多西他赛，顺铂和S-1治疗的晚期胃癌患者总体生存的替代指标。
3. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. [J] . Masahiro Hirakawa, Yasushi Sato, Hiroyuki Ohnuma, Cancer chemotherapy and pharmacology. . 2013,第3期

机译：II期新研究联合多西他赛，顺铂和S-1联合化疗治疗局部晚期可切除胃癌：核苷酸切除修复（NER）作为潜在的化学抗性标记。
4. A Successfully Treated Case of Stage IV Gastric Cancer with Outlet Stenosis Undergoing Curative Gastrectomy After Preoperative S-1 Plus Cisplatin Following Laparoscopic Assisted Gastrectomy. [C] . Y.Okumura, Y.Iwasaki, M.Ohashi, International Gastric Cancer Congress . 2009

机译：腹腔镜辅助胃切除术后，在术前S-1加顺铂术后成功处理了阶段IV胃癌的阶段胃癌。
5. P-034The potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated by preoperative docetaxel cisplatin and S-1 [O] . S. Fushida, H. Saito, T. Kurata, -1

机译：P-034术前多西紫杉醇顺铂和S-1治疗的晚期胃癌患者外渗血小板聚集作为整体生存的替代指标的潜力
6. Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study [O] . Saito, Hiroto, Fushida, Sachio, Miyashita, Tomoharu, 2017

机译：术前多西紫杉醇，顺铂和s-1治疗的晚期胃癌患者外渗血小板聚集作为总体生存的替代指标的潜力：回顾性观察研究

Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel cisplatin and S-1: a retrospective observational study

摘要

著录项

相似文献

相关主题

期刊订阅